1. Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study 
Kazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, Masahito Kajiya, Keisuke Okawa, Saori Tsukuda, Fumi Yokohama, Masahiro Sogo, Tomoyuki Nishibe, Naoaki Matsuo, Satoshi Hirohata, Hiroshi Ito, Masayuki Doi 
International Journal of Cardiology 
Volume 228, Pages (February 2017)
DOI: /j.ijcard
Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

2. Fig. 1
Study protocol.
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

3. Fig. 2
Flow diagram of this study. MI, myocardial infarction; CAG, coronary angiography; PCI, percutaneous coronary intervention; EPA, eicosapentaenoic acid.
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

4. Fig. 3
Serum levels of LDL-C (A) and triglyceride (B), and plasma levels of EPA (C) and EPA/AA (D). Values are the mean; error bars represent the 95% CI. Solid and broken lines indicate the EPA group and the control group, respectively.
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions

5. Fig. 4
Kaplan–Meier estimates of the incidence of a primary composite end point by 1year (A) and a secondary composite endpoint of either a primary end point or hospitalization for heart failure (B).
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions